LILRB4 Represents a Promising Target for Immunotherapy by Dual Targeting Tumor Cells and Myeloid-Derived Suppressive Cells in Multiple Myeloma.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)